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SATELLITE SYMPOSIUM: RENAL BIOPSY REGISTRIES
Introduction
Renal biopsy remains the main point of reference for
the diagnosis of renal diseases. In addition, it serves for
prognosis and therapy. The collection of clinical and lab-
oratory data at the time of renal biopsy and their inclu-
sion in a database is a useful tool for studying the initial
manifestations of the biopsied renal diseases. The avail-
ability of these data allows for epidemiologic studies in
health care for prevention and therapy. In fact, the renal
biopsy registries have shown that the annual incidence of
some primary glomerulonephritides in developed coun-
tries has changed in the course of the last 20 years (i.e.,
the decline of poststreptococcal glomerulonephritis and
of membranoproliferative glomerulonephritis due to bet-
ter public health and early antibiotic treatment of upper
respiratory tract infections).
The construction of a renal biopsy registry in each
country promotes many advantages such as linkage with
other registries, comparison in frequency of some re-
nal diseases, different policy in approaching renal biopsy
in some patients, identification of patients with rare
renal diseases [i.e., thin basement membrane disease
(TBMD)]. Thus, the registry is a source of epidemiologic
and clinical investigations. Moreover, it is the initial step
for studying the natural history of glomerular diseases
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and the follow-up, and to organize prospective clinical
studies. The combined use of renal replacement therapy
registries, which may include some biopsied patients with
end-stage renal disease (ESRD) and of the registries of
renal biopsy can be used to organize epidemiologic stud-
ies which give additional information on the long-term
outcome of patients with glomerulonephritis after renal
biopsy, mainly data on the risk of progression to ESRD
in each disease in a large sample of patients. In the case
of an additional collection of DNA samples from subjects
receiving renal biopsy, genetic studies correlated to the
phenotypic condition can give additional very important
information.
In conclusion, a correct management of long-term re-
nal biopsy registries allows retrospective and prospective
epidemiologic and clinical studies which contribute to the
knowledge of many aspects of the natural history of renal
diseases in the world. Thus, the renal registries have three
important positive aspects, considered epidemiology, ed-
ucation, and enhancement.
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